Is FRLN or DGRO a better dividend investment in 2026?

FRLN currently yields 30.82% with a 5% 5-year dividend growth rate. DGRO yields 2.13% with 9.5% growth. The better choice depends on your goal: FRLN offers higher current income.

What is the dividend yield difference between FRLN and DGRO?

FRLN has a forward dividend yield of 30.82% ($2.00/share annually). DGRO yields 2.13% ($1.47/share annually). The yield gap is 28.69 percentage points.

Home › Compare › FRLN vs DGRO

FRLN vs DGRO: Dividend Comparison 2026

FRLN yields 30.82% · DGRO yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 FRLN wins by $107.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

FRLN

● Live price

30.82%

Share price

$6.49

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$138.7K

Annual income

$18,790.33

Full FRLN calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.13%

Share price

$68.98

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$239.96

Full DGRO calculator →

Portfolio growth — FRLN vs DGRO

📍 FRLN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	FRLN	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, FRLN + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

FRLN pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FRLN

Annual income on $10K today (after 15% tax)

$2,619.41/yr

After 10yr DRIP, annual income (after tax)

$15,971.78/yr

DGRO

Annual income on $10K today (after 15% tax)

$181.24/yr

After 10yr DRIP, annual income (after tax)

$203.97/yr

At 15% tax rate, FRLN beats the other by $15,767.81/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FRLN + DGRO for your $10,000?

FRLN: 50%DGRO: 50%

100% DGRO50/50100% FRLN

Portfolio after 10yr

$85.2K

Annual income

$9,515.14/yr

Blended yield

11.17%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on FRLN right now

FRLN

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

-16.9

Piotroski

2/9

DGRO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FRLN buys

DGRO buys

No recent congressional trades found for FRLN or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricFRLNDGRO

Forward yield	30.82% ✓	2.13%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$138.7K ✓	$31.6K
Annual income after 10y	$18,790.33 ✓	$239.96
Total dividends collected	$95.7K ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: FRLN vs DGRO ($10,000, DRIP)

Year	FRLN Portfolio	FRLN Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$13,782	$3,081.66	$11,293	$213.22	+$2.5K → FRLN
2	$18,716	$3,969.20	$12,730	$217.32	+$6.0K → FRLN
3	$25,063	$5,037.57	$14,326	$221.10	+$10.7K → FRLN
4	$33,122	$6,304.80	$16,098	$224.56	+$17.0K → FRLN
5	$43,228	$7,787.05	$18,064	$227.74	+$25.2K → FRLN
6	$55,752	$9,498.01	$20,246	$230.65	+$35.5K → FRLN
7	$71,103	$11,448.37	$22,666	$233.30	+$48.4K → FRLN
8	$89,726	$13,645.43	$25,349	$235.73	+$64.4K → FRLN
9	$112,099	$16,092.82	$28,325	$237.94	+$83.8K → FRLN
10	$138,737	$18,790.33	$31,624	$239.96	+$107.1K → FRLN

FRLN vs DGRO: Complete Analysis 2026

FRLN — Stock

Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in Phase 1/2 clinical trials in adult males for the treatment of hemophilia B. The company's products also include FLT190, which is in Phase 1/2 clinical trial for the treatment of Fabry disease; and FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease and is under Phase 1/2 clinical trial. In addition, it has research programs in various indications for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.

Full FRLN Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this FRLN vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FRLN vs SCHD FRLN vs JEPI FRLN vs O FRLN vs KO FRLN vs MAIN FRLN vs VIG FRLN vs NOBL FRLN vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.